Akadeum Life Sciences, the leader in buoyant microbubble cell separation, today announced that its Chief Executive Officer Brandon McNaughton, PhD, will present at Biotech Showcase (TM) 2026 in San ...
Akadeum Life Sciences is pioneering buoyancy-based separation technologies that enable more effective and scalable cell isolation. Our mission is to create separation technologies to advance human ...
ANN ARBOR, Mich., Nov. 18, 2025 /PRNewswire/ -- Akadeum Life Sciences, the leader in buoyant cell separation, announced today that it has submitted a Type II Drug Master File (DMF) to the U.S. Food ...
ANN ARBOR, Mich., Oct. 2, 2025 /PRNewswire/ -- Akadeum Life Sciences, a leader in buoyancy-based cell separation technology, will present significant milestone updates of its next-generation cell ...
ANN ARBOR, Mich., Aug. 29, 2023 /PRNewswire/ -- Akadeum Life Sciences, the global leaders in buoyancy-based cell separation technology, have today announced the release of their 'Human T Cell ...
ANN ARBOR, Mich., Dec. 9, 2025 /PRNewswire/ -- Akadeum Life Sciences, the leader in buoyant cell separation, announces the establishment of the Akadeum CDMO Alliance™ and the first two members in the ...
ANN ARBOR, Mich., Oct. 30, 2019 /PRNewswire-PRWeb/ -- Akadeum Life Sciences, Inc., an Ann Arbor-based biotechnology company, announced today that it has entered into a collaboration with Agilent ...
Akadeum is unveiling this advancement and attending alongside partners at the American Society of Gene & Cell Therapy (ASGCT) 2025 Annual Meeting in New Orleans, May 13th-16 th. Throughout the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback